Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (Mangoral) and Oncoral – in clinical development. Ascelia Pharma has its global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE). For more information, please visit www.ascelia.com.
At Ascelia Pharma you will have the opportunity to join an ambitious and dedicated orphan-oncology company and be part of the journey to build a global life science organization.
If you submit your resume, we will review your information and contact you if any relevant positions become available.
What we offer
At Ascelia Pharma, your skills, dedication, and engagement help us improve the lives of people living with cancer. We offer you an opportunity to be part of a fast-growing company with global reach, where engagement, dedication and results are met with opportunities for individual and professional development.
Join us on our journey to improve patients’ lives and build a global orphan oncology life science organization.
Ascelia Pharma currently has two drug candidates – Orviglance and Oncoral – in clinical development. You can read more about them here.